Blasi E, Varesio L
Cell Immunol. 1984 Apr 15;85(1):15-24. doi: 10.1016/0008-8749(84)90273-9.
The role of protein synthesis during the activation of macrophages (M phi) by lymphokines (LK) was studied. Peritoneal murine macrophages elicited by proteose-peptone (pM phi) were activated with LK (supernatants from normal mouse spleen cells pulsed with concanavalin A) and tested for cytotoxicity in an 18 hr assay against 111In-labeled L5178Y lymphoma target cells. Reversible (cycloheximide and puromycin) or poorly reversible (emetine and pactamycin) inhibitors of protein synthesis were added during activation, and their effects on pM phi-mediated cytotoxicity and pM phi protein synthesis were measured. Minimal concentrations of inhibitors, reducing the rate of protein synthesis by more than 90% without toxic effects on macrophages, were chosen. Exposure of pM phi to LK for 2 to 18 hr in the presence of reversible inhibitors of protein synthesis did not affect the induction of cytolytic activity, indicating that protein synthesis was not required during the activation period. In contrast, activation of macrophages for 2 hr in the presence of poorly reversible inhibitors of protein synthesis resulted in a considerable reduction of cytolytic activity. The impairment of cytotoxic activity was also evident when pM phi were treated with such drugs during the first 2 hr of an 18 hr exposure to LK or when LK-activated macrophages were treated for 2 hr with the drugs before the addition of the targets. These results demonstrate that active protein synthesis is not required during the exposure of pM phi to LK, but that new proteins have to be synthesized to allow the expression of the cytotoxic activity in LK-activated pM phi.
研究了淋巴因子(LK)激活巨噬细胞(M phi)过程中蛋白质合成的作用。用蛋白胨诱导的腹膜小鼠巨噬细胞(pM phi)用LK(伴刀豆球蛋白A刺激的正常小鼠脾细胞的上清液)激活,并在18小时的试验中检测其对111In标记的L5178Y淋巴瘤靶细胞的细胞毒性。在激活过程中加入蛋白质合成的可逆抑制剂(环己酰亚胺和嘌呤霉素)或难逆抑制剂(依米丁和放线菌酮),并测量它们对pM phi介导的细胞毒性和pM phi蛋白质合成的影响。选择了能将蛋白质合成速率降低90%以上且对巨噬细胞无毒性作用的最低抑制剂浓度。在存在蛋白质合成可逆抑制剂的情况下,将pM phi暴露于LK 2至18小时不影响溶细胞活性的诱导,表明激活期不需要蛋白质合成。相反,在存在蛋白质合成难逆抑制剂的情况下,将巨噬细胞激活2小时会导致溶细胞活性显著降低。当pM phi在暴露于LK的18小时的前2小时用此类药物处理,或当LK激活的巨噬细胞在加入靶细胞前用药物处理2小时时,细胞毒性活性的损害也很明显。这些结果表明,pM phi暴露于LK期间不需要活跃的蛋白质合成,但必须合成新的蛋白质才能使LK激活的pM phi表达细胞毒性活性。